Loading insider details...
Latest Form 4 (Sep 9, 2026): Sale of 38,500 TRDA shares, $273.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 38,500 | $273.7K |
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 29,088 | $205.4K |
| Aug 31, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 38,922 | $280.2K |
| Aug 27, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 21,623 | $158.7K |
| Jul 8, 2026 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 35,770 | $11.4K |
| Jun 29, 2026 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 157,084 | $47.1K |
| Jun 10, 2026 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 76,928 | $28.5K |
| Jun 8, 2026 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 20,072 | $8.8K |
| Jun 3, 2026 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 80,459 | $37.8K |
| May 29, 2026 | Werewolf Therapeutics, Inc. (HOWL) | Sale | 80,852 | $38.8K |